AMPKβ isoform expression patterns in various adipocyte models and in relation to body mass index
(2022) In Frontiers in Physiology 13.- Abstract
AMP-activated protein kinase (AMPK) activation is considered a useful strategy for the treatment of type 2 diabetes (T2D). It is unclear whether the expression and/or activity of AMPK in adipocytes is dysregulated in obesity. Also, the expression/activity pattern of AMPKβ isoforms, which are targets for AMPK activators, in adipocytes remains elusive. In this study we show that the two AMPKβ isoforms make roughly equal contributions to AMPK activity in primary human and mouse adipocytes, whereas in cultured 3T3-L1 adipocytes of mouse origin and in primary rat adipocytes, β1-associated activity clearly dominates. Additionally, we found that obesity is not associated with changes in AMPK subunit expression or kinase activity in adipocytes... (More)
AMP-activated protein kinase (AMPK) activation is considered a useful strategy for the treatment of type 2 diabetes (T2D). It is unclear whether the expression and/or activity of AMPK in adipocytes is dysregulated in obesity. Also, the expression/activity pattern of AMPKβ isoforms, which are targets for AMPK activators, in adipocytes remains elusive. In this study we show that the two AMPKβ isoforms make roughly equal contributions to AMPK activity in primary human and mouse adipocytes, whereas in cultured 3T3-L1 adipocytes of mouse origin and in primary rat adipocytes, β1-associated activity clearly dominates. Additionally, we found that obesity is not associated with changes in AMPK subunit expression or kinase activity in adipocytes isolated from subcutaneous adipose tissue from individuals with various BMI.
(Less)
- author
- Kopietz, Franziska LU ; Degerman, Eva LU and Göransson, Olga LU
- organization
- publishing date
- 2022-08-04
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- adipocytes, AMPKβ, expression, human, kinase activity, obesity
- in
- Frontiers in Physiology
- volume
- 13
- article number
- 928964
- publisher
- Frontiers Media S. A.
- external identifiers
-
- scopus:85136460616
- pmid:35991175
- ISSN
- 1664-042X
- DOI
- 10.3389/fphys.2022.928964
- language
- English
- LU publication?
- yes
- id
- edbc410c-a121-4ee2-a45b-6c5ce8a7ca74
- date added to LUP
- 2023-01-03 16:26:59
- date last changed
- 2024-04-18 11:30:45
@article{edbc410c-a121-4ee2-a45b-6c5ce8a7ca74, abstract = {{<p>AMP-activated protein kinase (AMPK) activation is considered a useful strategy for the treatment of type 2 diabetes (T2D). It is unclear whether the expression and/or activity of AMPK in adipocytes is dysregulated in obesity. Also, the expression/activity pattern of AMPKβ isoforms, which are targets for AMPK activators, in adipocytes remains elusive. In this study we show that the two AMPKβ isoforms make roughly equal contributions to AMPK activity in primary human and mouse adipocytes, whereas in cultured 3T3-L1 adipocytes of mouse origin and in primary rat adipocytes, β1-associated activity clearly dominates. Additionally, we found that obesity is not associated with changes in AMPK subunit expression or kinase activity in adipocytes isolated from subcutaneous adipose tissue from individuals with various BMI.</p>}}, author = {{Kopietz, Franziska and Degerman, Eva and Göransson, Olga}}, issn = {{1664-042X}}, keywords = {{adipocytes; AMPKβ; expression; human; kinase activity; obesity}}, language = {{eng}}, month = {{08}}, publisher = {{Frontiers Media S. A.}}, series = {{Frontiers in Physiology}}, title = {{AMPKβ isoform expression patterns in various adipocyte models and in relation to body mass index}}, url = {{http://dx.doi.org/10.3389/fphys.2022.928964}}, doi = {{10.3389/fphys.2022.928964}}, volume = {{13}}, year = {{2022}}, }